POSTPRANDIAL DECREASE IN HDL CHOLESTEROL AND HDL APO A-I IN NORMAL SUBJECTS IN RELATION TO TRIGLYCERIDE-METABOLISM

被引:69
作者
DEBRUIN, TWA
BROUWER, CB
GIMPEL, JA
ERKELENS, DW
机构
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 260卷 / 03期
关键词
VITAMIN-A; NUTRITION; SATURATED FAT; LIPOPROTEIN LIPASE; HEPATIC LIPASE; CHYLOMICRONS;
D O I
10.1152/ajpendo.1991.260.3.E492
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The postprandial lipoprotein metabolism is important since it determines the circulation of potentially atherogenic particles and influences the metabloism of high-density lipoproteins (HDL) in a complex manner that is at present not completely understood. Therefore the short-term (24-h) changes in postprandial lipoprotein metabolism, including retinyl palmitate (RP), apolipoprotein A-I (apo A-I), and apolipoprotein B, were studied in relation to postheparin lipolytic activities in six healthy normolipidemic men after an oral RP fat tolerance test. The fat load (98 g) was cleared in 7 h, because the triglyceride (TG) concentrations had returned to initial values (0.72 +/- 0.31 mmol/l at that time. RP showed a peak in plasma at 4 and 5 h but remained present in chylomicron (remnants) in low concentrations after 8 and 24 h. After the fat load, HDL cholesterol and HDL-associated apo A-I showed a significant decrease in concentration of 35 and 29%, respectively. The decrease coincided with the increase in chylomicron remnants and the transient appearance of TG-enriched HDL. Hepatic lipase was correlated to both the initial HDL cholesterol concentration as well as the peak concentration of TG in chylomicron remnants, suggesting that it could be one of the regulating common physiological pathways in postprandial HDL and TG metabolism. In the subjects studied, the atherogenic potential of plasma increased in response to an oral fat load, characterized by a decrease in HDL cholesterol and HDL-associated apo A-I.
引用
收藏
页码:E492 / E498
页数:7
相关论文
共 31 条
[1]   DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL [J].
ARNTZENIUS, AC ;
KROMHOUT, D ;
BARTH, JD ;
REIBER, JHC ;
BRUSCHKE, AVG ;
BUIS, B ;
VANGENT, CM ;
KEMPENVOOGD, N ;
STRIKWERDA, S ;
VANDERVELDE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :805-811
[2]  
BAMBERGER M, 1983, J LIPID RES, V24, P869
[3]  
BARTER PJ, 1975, J LAB CLIN MED, V85, P261
[4]   EVIDENCE INVITRO THAT HEPATIC LIPASE REDUCES THE CONCENTRATION OF APOLIPOPROTEIN-A-I IN RABBIT HIGH-DENSITY LIPOPROTEINS [J].
CLAY, MA ;
RYE, KA ;
BARTER, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (01) :50-56
[5]  
COHN JS, 1988, J LIPID RES, V29, P469
[6]   ALIMENTARY LIPEMIA-INDUCED REDISTRIBUTION OF CHOLESTERYL ESTER BETWEEN LIPOPROTEINS - STUDIES IN NORMOLIPIDEMIC, COMBINED HYPERLIPIDEMIC, AND HYPERCHOLESTEROLEMIC MEN [J].
DULLAART, RPF ;
GROENER, JEM ;
VANWIJK, H ;
SLUITER, WJ ;
ERKELENS, DW .
ARTERIOSCLEROSIS, 1989, 9 (05) :614-622
[7]   EPITOPES OF APOLIPOPROTEIN-B-100 AND APOLIPOPROTEIN-B-48 IN BOTH LIVER AND INTESTINE - EXPRESSION AND EVIDENCE FOR LOCAL SYNTHESIS IN RECESSIVE ABETALIPOPROTEINEMIA [J].
DULLAART, RPF ;
SPEELBERG, B ;
SCHUURMAN, HJ ;
MILNE, RW ;
HAVEKES, LM ;
MARCEL, YL ;
GEUZE, HJ ;
HULSHOF, MM ;
ERKELENS, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1397-1404
[8]  
EISENBERG S, 1984, J LIPID RES, V25, P1017
[9]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[10]  
GORDON DJ, 1989, NEW ENGL J MED, V321, P1311